161
Views
1
CrossRef citations to date
0
Altmetric
Case Report

A Case of Thrombocytosis Associated with Enoxaparin Therapy in an Adolescent

ORCID Icon & ORCID Icon
Pages 203-207 | Published online: 18 Oct 2021

References

  • Skoda RC. Thrombocytosis. Hematology. 2009;2009:159–167. doi:10.1182/asheducation-2009.1.159
  • Harrison CN, Bareford D, Butt N, et al. Guideline for investigation and management of adults and children presenting with a thrombocytosis. Br J Haemat. 2010;149:352–375. doi:10.1111/j.1365-2141.2010.08122.x20331456
  • Yohannan MD, Higgy KE, Al-Mashhadani SA, Santhosh-Kumar CR. Thrombocytosis. Clin Pediatr. 1994;33:340–343. doi:10.1177/000992289403300605
  • Hofmann T. Clinical application of enoxaparin. Expert Rev Cardiovasc Ther. 2004;2:321–337. doi:10.1586/14779072.2.3.32115151480
  • Ranze O, Ranze P, Magnani HN, et al. Heparin-induced thrombocytopenia in paediatric patients: a review of the literature and a new case treated with danaparoid sodium. Eur J Pediatr. 1999;158(suppl 3):S130–3. doi:10.1007/PL0001433810650852
  • Tonbul A, Uras N, Tayman C, Halici T, Polat A, Mansur Tatli M. Thrombocytosis associated with enoxaparin: a very rare cause in newborns. Platelets. 2010;21:300–302. doi:10.3109/0953710100364980720367573
  • Xiang T, Cheng M. Enoxaparin-induced reactive thrombocytosis: a case report. Thromb J. 2021;19:34. doi:10.1186/s12959-021-00290-x34039362
  • Hummel MC, Morse BC, Hayes LE. Reactive thrombocytosis associated with enoxaparin. Pharmacotherapy. 2006;26:1667–1670. doi:10.1592/phco.26.11.166717064215
  • Ziaja K, Simka M, Krupowies A, Dugaj M, Ludyga T. Thrombocytosis after prophylactic administration of enoxaparin: unexpected findings in a Polish prospective multicenter trial on the efficacy and safety of enoxaparin in the prevention of postoperative thromboembolism. Int Angiol. 1999;18:65–69.10392483
  • Shen ZX, Basara N, Xi XD, et al. Fraxiparin, a low-molecular-weight heparin, stimulates megakaryocytopoiesis in vitro and in vivo in mice. Br J Haematol. 1994;88:608–612. doi:10.1111/j.1365-2141.1994.tb05080.x7819073
  • Han ZC, Bellucci S, Shen ZX, et al. Glycosaminoglycans enhance megakaryocytopoiesis by modifying the activities of hematopoietic growth regulators. J Cell Physiol. 1996;168:97–104. doi:10.1002/(SICI)1097-4652(199607)168:1<97::AID-JCP12>3.0.CO;2-M8647928
  • Buss DH, Stuart JJ, Lipscomb GE. The incidence of thrombotic and hemorrhagic disorders in association with extreme thrombocytosis: an analysis of 129 cases. Am J Hematol. 1985;20:365–372. doi:10.1002/ajh.28302004083865532
  • Randi ML, Stocco F, Rossi C, Tison T, Girolami A. Thrombosis and hemorrhage in thrombocytosis: evaluation of a large cohort of patients (357 cases). J Med. 1991;22:213–223.1787383